Fundraising FoxBugworks Research
Wilmington, US · Founded 2014 · Delaware corporation · 9 known investors
Find your way into Bugworks Research
Each arrow is one introduction. Sign up to fill in the first one.
Ask Pranav Pai to introduce you to Anand Anandkumar
You →Pranav · together at Bugworks Research →Anand
Sign up to find every way you can get introduced to Bugworks Research
- Your email: who you already know at Bugworks Research, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Bugworks Research team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Bugworks Research is a drug discovery company developing small molecule therapeutics, including novel antibacterial agents targeting antimicrobial resistance (AMR) across Gram-negative and Gram-positive infections and next-generation immuno-oncology treatments for hard-to-treat tumors. Its research focuses on affordable oral and intravenous therapies for serious hospital and community infections and cancer.
Founders & leadership
Bugworks Research was founded in 2014 by Anand Anandkumar.
Investors · 9
How we know: 3one4 Capital's portfolio page · Not right? Tell us
How we know: funding news · economictimes.indiatimes.com · globalbrains.com · Not right? Tell us
Also in the syndicate · 7
Reported raises · per SEC filings
Form D private placements$39.1M disclosed across 5 rounds · 2015–2024
▶$6.8MraisedMar 2024 · 15 investors · BiotechnologyRule 506(b)
- Pradeep FernandesExecutive Officer
- Santanu DattaDirector
- Anand AnandkumarExecutive Officer, Director
- Tejasvi RaviDirector
- Atsushi UsamiDirector
- Venkataraman SubramanianDirector
- Offering amount
- $15.8M
- Amount sold
- $6.8M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16MraisedDec 2021 · 19 investors · BiotechnologyRule 506(b)
- Bala SubramanianExecutive Officer, Director
- Pradeep FernandesExecutive Officer
- Santanu DattaExecutive Officer, Director
- Atsushi UsamiDirector
- Anand AnandkumarExecutive Officer, Director
- Tejasvi RaviDirector
- Offering amount
- $19.4M
- Amount sold
- $16M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedNov 2020 · 3 investors · PharmaceuticalsRule 506(b)
- Anand AnandkumarExecutive Officer, Director
- Santanu DattaExecutive Officer, Director
- Pradeep FernandesExecutive Officer
- Bala SubramanianExecutive Officer, Director
- Atsushi UsamiDirector
- Offering amount
- $6.2M
- Amount sold
- $6.2M
- Minimum investment
- $250K
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.5MraisedAug 2018 · 13 investors · Other TechnologyRule 506(b)
- Atushi UsamiDirector
- Anand AnandkumarExecutive Officer, Director
- Pradeep FernandesExecutive Officer
- Bala SubramanianDirector
- Santanu DattaDirector
- Offering amount
- $9.2M
- Amount sold
- $8.5M
- Minimum investment
- $95.8K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.6MraisedNov 2015 · 7 investors · Other TechnologyRule 506(b)
- Anand AnandkumarExecutive Officer
- Offering amount
- $2.3M
- Amount sold
- $1.6M
- Minimum investment
- $26.5K
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Bugworks Research.
In the news
Frequently asked questions
- What does Bugworks Research do?
- Bugworks Research is a drug discovery company developing small molecule therapeutics, including novel antibacterial agents targeting antimicrobial resistance (AMR) across Gram-negative and Gram-positive infections and next-generation immuno-oncology treatments for hard-to-treat tumors. Its research focuses on affordable oral and intravenous therapies for serious hospital and community infections and cancer.
- Who founded Bugworks Research?
- Bugworks Research was founded by Anand Anandkumar in 2014.
- Who are Bugworks Research's investors?
- Bugworks Research's investors include 3one4 Capital, Global Brain.
- How much funding has Bugworks Research raised?
- Bugworks Research has disclosed $39.1M raised across 5 rounds.
- Where is Bugworks Research headquartered?
- Bugworks Research is headquartered in Wilmington, US.